IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,295 | +435.1% | 93,697 | +490.4% | 0.00% | – |
| Q2 2023 | $168,617 | +58.8% | 15,871 | +57.3% | 0.00% | – |
| Q1 2023 | $106,160 | -34.1% | 10,091 | -22.0% | 0.00% | – |
| Q4 2022 | $161,000 | +3.9% | 12,942 | -14.3% | 0.00% | – |
| Q3 2022 | $155,000 | -9.9% | 15,103 | +0.7% | 0.00% | – |
| Q2 2022 | $172,000 | -9.0% | 14,998 | +0.1% | 0.00% | – |
| Q1 2022 | $189,000 | +11.8% | 14,985 | +3.8% | 0.00% | – |
| Q4 2021 | $169,000 | +59.4% | 14,432 | +77.2% | 0.00% | – |
| Q3 2021 | $106,000 | +278.6% | 8,143 | +267.6% | 0.00% | – |
| Q2 2021 | $28,000 | +55.6% | 2,215 | +34.7% | 0.00% | – |
| Q1 2021 | $18,000 | -35.7% | 1,645 | -30.2% | 0.00% | – |
| Q4 2020 | $28,000 | +86.7% | 2,356 | +39.4% | 0.00% | – |
| Q3 2020 | $15,000 | -44.4% | 1,690 | -34.5% | 0.00% | – |
| Q2 2020 | $27,000 | +1250.0% | 2,580 | +1729.8% | 0.00% | – |
| Q1 2020 | $2,000 | – | 141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |